US Patent 9474727 Pharmaceutical compositions of curcumin
Patent 9474727 was granted and assigned to Cadila Pharmaceuticals on October, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+423 characters)
Article
Patent abstract
The present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and/or molecular aggregation inhibitor(s). In accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Ashish Premkumar Gogia0
Bakulesh Mafatlal Khamar0
Chirag Chandrakant Goda0
Dinesh Balkunje Shenoy0
Imran Ahmad Khan0
Indravadan Ambalal Modi0
Rajneesh Ramesh Shrivastava0
Ritu Nitin Laddha0
Vandana Bharat Patravale0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09474727 Pharmaceutical compositions of curcumin US Patent 9474727 Pharmaceutical compositions of curcumin
Infobox
Patent Number
09474727
Patent Number
9474727
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09474727 Pharmaceutical compositions of curcumin
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09474727
Date of patent
October 25, 2016
Patent application number
13822539
Date Filed
September 12, 2011
Patent primary examiner
Find more entities like US Patent 9474727 Pharmaceutical compositions of curcumin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.